US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

GRI

GRI Bio (GRI)

GRI Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GRI

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/14	21 : 05	GlobeNewswire Inc.	GRI Bio Announces Reverse Stock Split	NASDAQ:GRI	GRI Bio Inc
2024/06/11	22 : 00	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor Pitch Conference	NASDAQ:GRI	GRI Bio Inc
2024/05/22	22 : 15	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) Programs	NASDAQ:GRI	GRI Bio Inc
2024/05/21	21 : 35	GlobeNewswire Inc.	GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)	NASDAQ:GRI	GRI Bio Inc
2024/05/20	21 : 45	GlobeNewswire Inc.	GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)	NASDAQ:GRI	GRI Bio Inc
2024/05/14	22 : 05	GlobeNewswire Inc.	GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company Showcase	NASDAQ:GRI	GRI Bio Inc
2024/05/13	21 : 00	GlobeNewswire Inc.	GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:GRI	GRI Bio Inc
2024/04/29	21 : 45	GlobeNewswire Inc.	GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity	NASDAQ:GRI	GRI Bio Inc
2024/04/25	22 : 15	GlobeNewswire Inc.	GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar	NASDAQ:GRI	GRI Bio Inc
2024/04/16	21 : 35	GlobeNewswire Inc.	GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent	NASDAQ:GRI	GRI Bio Inc
2024/04/08	21 : 35	GlobeNewswire Inc.	GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference	NASDAQ:GRI	GRI Bio Inc
2024/04/01	20 : 35	GlobeNewswire Inc.	GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:GRI	GRI Bio Inc
2024/03/28	22 : 00	GlobeNewswire Inc.	GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference	NASDAQ:GRI	GRI Bio Inc
2024/03/14	21 : 45	GlobeNewswire Inc.	GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators	NASDAQ:GRI	GRI Bio Inc
2024/03/04	22 : 30	GlobeNewswire Inc.	GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom	NASDAQ:GRI	GRI Bio Inc
2024/02/02	22 : 00	GlobeNewswire Inc.	GRI Bio Announces Pricing of $5.5 Million Public Offering	NASDAQ:GRI	GRI Bio Inc
2024/01/26	22 : 05	GlobeNewswire Inc.	GRI Bio Announces Reverse Stock Split	NASDAQ:GRI	GRI Bio Inc
2023/12/05	23 : 05	GlobeNewswire Inc.	GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)	NASDAQ:GRI	GRI Bio Inc
2023/11/27	22 : 35	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) Announces FDA Clearance of IND for Lead Program GRI-0621, a Type 1 Invariant NKT (“iNKT”) Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)	NASDAQ:GRI	GRI Bio Inc
2023/11/15	22 : 05	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:GRI	GRI Bio Inc
2023/10/31	21 : 45	GlobeNewswire Inc.	GRI Bio Presents Data Supporting Innovative Pipeline of NKT Cell Modulators for the Treatment of High-Value Inflammatory, Fibrotic and Autoimmune Diseases	NASDAQ:GRI	GRI Bio Inc
2023/10/19	21 : 45	GlobeNewswire Inc.	GRI Bio Presents Translational Data Demonstrating Connection Between NKT Cells and the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) at the 2023 Pittsburgh-Ireland International Lung Conference	NASDAQ:GRI	GRI Bio Inc
2023/10/17	21 : 35	GlobeNewswire Inc.	GRI Bio Announces Partnership with the Respiratory Translational Research Collaboration to Advance Leading NKT Regulation Technology Targeting Earlier in the Inflammatory Cascade to Modulate Disease Progression	NASDAQ:GRI	GRI Bio Inc
2023/10/11	22 : 05	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO Conference	NASDAQ:GRI	GRI Bio Inc
2023/10/05	21 : 45	GlobeNewswire Inc.	GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review in Frontiers in Immunology Demonstrating a Key Role of Type 1 iNKT Cells in Modulating Various Fibrotic Conditions	NASDAQ:GRI	GRI Bio Inc
2023/09/06	22 : 05	GlobeNewswire Inc.	GRI Bio to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:GRI	GRI Bio Inc
2023/08/23	22 : 00	GlobeNewswire Inc.	GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIR	NASDAQ:GRI	GRI Bio Inc
2023/08/14	21 : 05	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) Reports Second Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:GRI	GRI Bio Inc
2023/08/07	21 : 35	GlobeNewswire Inc.	GRI Bio Presents Encouraging Preclinical Data Indicating Oral Administration of GRI-0803 Inhibited Lupus Nephritis and Significantly Improved Overall Survival in Animal Models	NASDAQ:GRI	GRI Bio Inc
2023/08/03	21 : 30	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) to Present at Benzinga’s Virtual Biotech Conference	NASDAQ:GRI	GRI Bio Inc

Showing the most relevant articles for your search:NASDAQ:GRI

US Dollar vs Sterling

Health Care Select Sector

JP Morgan Chase

US Dollar vs Yen

Gold vs US Dollar

Energy Select Sector SPDR

Verizon Communications

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約